Protalix BioTherapeutics Inc(PLX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PLX Protalix BioTherapeutics Inc

交易中 12-11 15:52:05 EST

1.84

+0.04

+2.22%

最高1.85	最低1.76	成交量46.38万
今开1.78	昨收1.80	日振幅5.00%
总市值1.48亿	流通市值1.12亿	总股本8,042万
成交额84.19万	换手率0.76%	流通股本6,076万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PLX","market":"US","secType":"STK","nameCN":"Protalix BioTherapeutics Inc","latestPrice":1.84,"timestamp":1765486292060,"preClose":1.8,"halted":0,"volume":463765,"delay":0,"floatShares":60755281,"shares":80421181,"eps":0.069071,"marketStatus":"交易中","change":0.04,"latestTime":"12-11 15:52:05 EST","open":1.78,"high":1.85,"low":1.76,"amount":841933.9606095001,"amplitude":0.05,"askPrice":1.85,"askSize":586,"bidPrice":1.84,"bidSize":1510,"shortable":3,"etf":0,"ttmEps":0.069071,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765486800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":829022400000,"exchange":"AMEX","adjPreClose":1.8,"preHourTrading":{"tag":"盘前","latestPrice":1.81,"preClose":1.8,"latestTime":"09:16 EST","volume":4853,"amount":8770.429924600001,"timestamp":1765462600657},"postHourTrading":{"tag":"盘后","latestPrice":1.8,"preClose":1.8,"latestTime":"17:24 EST","volume":91836,"amount":165303.17,"timestamp":1765405472635},"volumeRatio":0.987418,"impliedVol":0.0585,"impliedVolPercentile":0.068},"requestUrl":"/m/hq/s/PLX/tweets","defaultTab":"tweets","newsList":[{"id":"1150104851","title":"Protalix BioTherapeutics 第三季度每股收益为0.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1150104851","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150104851?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:40","pubTimestamp":1763574048,"startTime":"0","endTime":"0","summary":"11月13日 - Protalix BioTherapeutics 第三季度税前利润为223.9万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"1106718567","title":"奇耶斯全球罕见疾病请求欧洲药品管理局对Elfabrio 2 mg/kg每四周给药方案的负面意见进行重新审查","url":"https://stock-news.laohu8.com/highlight/detail?id=1106718567","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106718567?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:30","pubTimestamp":1763569859,"startTime":"0","endTime":"0","summary":"11月3日——奇耶斯全球罕见疾病公司请求欧洲药品管理局（EMA）药物评审委员会（CHMP）对其提出的每四周给药2 mg/kg的Elfabrio方案的负面意见进行重新审查。奇耶斯全球罕见疾病公司和Protalix BioTherapeutics正在向EMA申请重新审查Elfabrio（Pegunigalsidase Alfa）在欧盟的替代给药方案的负面意见。目前Elfabrio的现有市场授权仍然有效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"1183889421","title":"Protalix BioTherapeutics 第三季度每股收益为0.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183889421","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183889421?lang=zh_cn&edition=full","pubTime":"2025-11-13 20:09","pubTimestamp":1763035744,"startTime":"0","endTime":"0","summary":"11月13日 - Protalix BioTherapeutics 第三季度税前利润为223.9万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"1189273756","title":"奇耶西全球罕见病公司申请重新审查欧洲药品管理局CHMP对Elfabrio 2 mg/kg每4周给药方案的负面意见","url":"https://stock-news.laohu8.com/highlight/detail?id=1189273756","media":"投资观察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189273756?lang=zh_cn&edition=full","pubTime":"2025-11-04 07:47","pubTimestamp":1762213677,"startTime":"0","endTime":"0","summary":"11月3日（路透社） - 奇耶西全球罕见病公司请求重新审查欧洲药品管理局（EMA）药品人用委员会（CHMP）对Elfabrio（PEGUNIGALSIDASE ALFA）每4周2 mg/kg给药方案的负面意见，同时与Protalix BioTherapeutics共同寻求对此持否定态度的重新审查。现有的Elfabrio市场授权依然生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2573983236","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 下午盘股价大涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573983236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573983236?lang=zh_cn&edition=full","pubTime":"2025-10-07 02:09","pubTimestamp":1759774187,"startTime":"0","endTime":"0","summary":"北京时间2025年10月07日02时09分，Protalix Biotherapeutics, Inc. 股票出现波动，股价快速拉升5.35%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Leap Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Kalaris Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Leap Therapeutics, Inc.、Cdt Equity Inc.较为活跃，换手率分别为474.88%、216.68%、143.27%，振幅较大的相关个股有Leap Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Moolec Science Sa C/Wts ，振幅分别为61.63%、56.38%、50.94%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251007020947a6af0b7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251007020947a6af0b7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2570080102","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 临近收盘急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570080102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570080102?lang=zh_cn&edition=full","pubTime":"2025-09-25 03:39","pubTimestamp":1758742759,"startTime":"0","endTime":"0","summary":"北京时间2025年09月25日03时39分，Protalix Biotherapeutics, Inc. 股票出现波动，股价大幅拉升5.10%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Uniqure N.V.、Tnf Pharmaceuticals, Inc.、Akari Therapeutics Plc涨幅较大，Tnf Pharmaceuticals, Inc.、Cyclerion Therapeutics, Inc.、Uniqure N.V.较为活跃，换手率分别为3194.88%、442.20%、121.12%，振幅较大的相关个股有Tnf Pharmaceuticals, Inc.、Uniqure N.V.、Akari Therapeutics Plc，振幅分别为135.04%、103.15%、60.49%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925033919a69be85e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925033919a69be85e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2566612950","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 快速拉升5.06%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566612950","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566612950?lang=zh_cn&edition=full","pubTime":"2025-09-10 00:33","pubTimestamp":1757435599,"startTime":"0","endTime":"0","summary":"北京时间2025年09月10日00时33分，Protalix Biotherapeutics, Inc. 股票出现波动，股价急速上涨5.06%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.51%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910003320a4beddbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910003320a4beddbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2558646106","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 急速拉升5.19%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558646106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558646106?lang=zh_cn&edition=full","pubTime":"2025-08-12 00:07","pubTimestamp":1754928478,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日00时07分，Protalix Biotherapeutics, Inc. 股票出现波动，股价大幅拉升5.19%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5804.94%、551.05%、187.28%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081200075897411f13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081200075897411f13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2557304456","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 临近收盘急速拉升5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557304456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557304456?lang=zh_cn&edition=full","pubTime":"2025-08-07 03:47","pubTimestamp":1754509632,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日03时47分，Protalix Biotherapeutics, Inc. 股票出现异动，股价急速拉升5.28%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Biomx Inc.、天演药业、Avidity Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为784.07%、731.35%、129.19%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Cingulate Inc C/Wts 10/12/2026 、Biomx Inc.，振幅分别为57.18%、51.96%、51.84%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080703471297380f2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080703471297380f2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2557319926","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 急速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557319926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557319926?lang=zh_cn&edition=full","pubTime":"2025-08-06 03:29","pubTimestamp":1754422192,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日03时29分，Protalix Biotherapeutics, Inc. 股票出现异动，股价快速跳水5.00%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为3.59%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806032952a4771baf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806032952a4771baf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2552439678","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 快速拉升5.59%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552439678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552439678?lang=zh_cn&edition=full","pubTime":"2025-07-18 03:00","pubTimestamp":1752778821,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日03时00分，Protalix Biotherapeutics, Inc. 股票出现波动，股价急速上涨5.59%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.16%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718030022a451a7c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718030022a451a7c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2551126507","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 急速上涨5.07%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551126507","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551126507?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:39","pubTimestamp":1752673186,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时39分，Protalix Biotherapeutics, Inc. 股票出现异动，股价快速上涨5.07%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.84%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716213946a6ada46a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716213946a6ada46a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2550676878","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 临近收盘快速跳水5.22%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550676878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550676878?lang=zh_cn&edition=full","pubTime":"2025-07-11 03:57","pubTimestamp":1752177449,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日03时57分，Protalix Biotherapeutics, Inc. 股票出现异动，股价大幅下挫5.22%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Q32 Bio Inc.、Pelthos Therapeutics Inc.、Lixte Biotechnology Holdings, Inc.涨幅较大，Q32 Bio Inc.、Cognition Therapeutics, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为452.59%、391.66%、361.37%，振幅较大的相关个股有Q32 Bio Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Pelthos Therapeutics Inc.，振幅分别为146.36%、95.79%、85.25%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711035729a4432187&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711035729a4432187&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2549554763","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 急速下挫5.19%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549554763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549554763?lang=zh_cn&edition=full","pubTime":"2025-07-08 02:18","pubTimestamp":1751912309,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日02时18分，Protalix Biotherapeutics, Inc. 股票出现异动，股价大幅下挫5.19%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为1.03%。其相关个股中，Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Vor Biopharma Inc.涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为6073.69%、1254.35%、908.06%，振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为306.72%、233.18%、103.43%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708021830a43c4996&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708021830a43c4996&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2547909040","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 早盘快速跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547909040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547909040?lang=zh_cn&edition=full","pubTime":"2025-06-30 22:08","pubTimestamp":1751292529,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日22时08分，Protalix Biotherapeutics, Inc. 股票出现波动，股价大幅下跌5.19%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为2856.65%、234.25%、86.70%，振幅较大的相关个股有Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Vor Biopharma Inc.，振幅分别为106.76%、56.94%、34.91%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063022084995315a5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063022084995315a5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2546726436","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 股价大涨5.17%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546726436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546726436?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:12","pubTimestamp":1751051531,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时12分，Protalix Biotherapeutics, Inc. 股票出现波动，股价大幅拉升5.17%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为0.68%。其相关个股中，Eyenovia, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、天境生物涨幅较大，Inmune Bio Inc.、Hcw Biologics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为239.53%、165.70%、135.55%，振幅较大的相关个股有Inmune Bio Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Channel Therapeutics Corporation，振幅分别为105.57%、74.75%、64.91%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506280312119791ba79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506280312119791ba79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2546753455","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546753455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546753455?lang=zh_cn&edition=full","pubTime":"2025-06-27 01:37","pubTimestamp":1750959465,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日01时37分，Protalix Biotherapeutics, Inc. 股票出现波动，股价大幅上涨5.36%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Vor Biopharma Inc.、Moolec Science Sa C/Wts 、Adial Pharmaceuticals, Inc涨幅较大，Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1315.13%、300.35%、219.32%，振幅较大的相关个股有Vor Biopharma Inc.、Moolec Science Sa C/Wts 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为98.85%、61.67%、46.79%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627013745a71f416c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627013745a71f416c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2546924993","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 早盘股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546924993","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546924993?lang=zh_cn&edition=full","pubTime":"2025-06-25 22:18","pubTimestamp":1750861082,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日22时18分，Protalix Biotherapeutics, Inc. 股票出现异动，股价大幅下挫5.23%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为0.83%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625221803952b4863&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625221803952b4863&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2545223303","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 股价大涨5.10%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545223303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545223303?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:54","pubTimestamp":1750773254,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日21时54分，Protalix Biotherapeutics, Inc. 股票出现异动，股价急速上涨5.10%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，内克塔治疗、Vor Biopharma Inc.、Ibio, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Ibio, Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为507.93%、319.04%、246.85%，振幅较大的相关个股有Vor Biopharma Inc.、内克塔治疗、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为48.55%、38.68%、37.60%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506242154159529ad41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506242154159529ad41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2514373584","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 早盘大幅下跌5.15%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514373584?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:35","pubTimestamp":1740753342,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时35分，Protalix Biotherapeutics, Inc. 股票出现波动，股价快速下跌5.15%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Enveric Biosciences, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Virpax Pharmaceuticals, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为492.73%、249.70%、156.36%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Enveric Biosciences, Inc.、Anaptysbio, Inc.，振幅分别为31.14%、27.83%、16.10%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822354298967ae3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822354298967ae3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PLX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.protalix.com","stockEarnings":[{"period":"1week","weight":0.0465},{"period":"1month","weight":-0.1549},{"period":"3month","weight":0.0345},{"period":"6month","weight":0.2081},{"period":"1year","weight":-0.0164},{"period":"ytd","weight":-0.0426}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Protalix Biotherapeutics, Inc.最初于1992年4月在佛罗里达州注册成立，并于2016年3月在特拉华州重新注册成立。该公司是一家生物制药公司，专注于开发、生产和商业化由专有的ProCellEx植物细胞蛋白表达系统生产的重组治疗蛋白。该公司是第一家也是唯一一家获得FDA批准的通过植物细胞表达悬浮蛋白生产的公司。该公司独特的表达系统代表了一种以工业规模开发重组蛋白的新方法。该公司的战略重点是开发主要通过ProCellEx生产的定制复杂重组治疗性蛋白质，同时在生产前和生产后对蛋白质进行基因工程和化学修饰。该公司打算通过改进治疗蛋白的生物学特性（例如，糖基化、半衰期、免疫原性），进行此类工程设计和修改，以提供额外的临床益处。","yearOnYearQuotes":[{"month":1,"riseRate":0.722222,"avgChangeRate":0.111668},{"month":2,"riseRate":0.388889,"avgChangeRate":0.044341},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.033546},{"month":4,"riseRate":0.578947,"avgChangeRate":0.056427},{"month":5,"riseRate":0.210526,"avgChangeRate":-0.051275},{"month":6,"riseRate":0.421053,"avgChangeRate":-0.034716},{"month":7,"riseRate":0.368421,"avgChangeRate":-0.04582},{"month":8,"riseRate":0.368421,"avgChangeRate":-0.012213},{"month":9,"riseRate":0.421053,"avgChangeRate":0.05112},{"month":10,"riseRate":0.421053,"avgChangeRate":-0.052252},{"month":11,"riseRate":0.368421,"avgChangeRate":-0.008211},{"month":12,"riseRate":0.421053,"avgChangeRate":-0.008649}],"exchange":"AMEX","name":"Protalix BioTherapeutics Inc","nameEN":"Protalix BioTherapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Protalix BioTherapeutics Inc(PLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Protalix BioTherapeutics Inc(PLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Protalix BioTherapeutics Inc,PLX,Protalix BioTherapeutics Inc股票,Protalix BioTherapeutics Inc股票老虎,Protalix BioTherapeutics Inc股票老虎国际,Protalix BioTherapeutics Inc行情,Protalix BioTherapeutics Inc股票行情,Protalix BioTherapeutics Inc股价,Protalix BioTherapeutics Inc股市,Protalix BioTherapeutics Inc股票价格,Protalix BioTherapeutics Inc股票交易,Protalix BioTherapeutics Inc股票购买,Protalix BioTherapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Protalix BioTherapeutics Inc(PLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Protalix BioTherapeutics Inc(PLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}